Evidence map›Paper›PMID 40851803›Full record

ReviewFrontiers in cellular and infection microbiology2025

The untapped potential of vaginal microbiome diagnostics for improving women's health.

Ana Sofia Da Silva, Saba Anwar, Suenie Park, Sunwha Park, Laura Goodfellow, Chrysi Sergaki

Abstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Vaginal microbiome and its implications in preterm birth.Obstetrics & gynecology science · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ana Sofia Da Silva *Department of Urogynaecology, King's College Hospital, London, United Kingdom.
Saba Anwar *Science and Research, Medicines and Healthcare Products Regulatory Agency, Potter's Bar, United Kingdom.
Suenie ParkMicrobiome Research Center, BiowaveW, Corelab, Seoul, Republic of Korea.
Sunwha ParkMicrobiome Research Center, BiowaveW, Corelab, Seoul, Republic of Korea.
Laura GoodfellowWomen's and Children's Health, University of Liverpool, Liverpool, United Kingdom.
Chrysi SergakiScience and Research, Medicines and Healthcare Products Regulatory Agency, Potter's Bar, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbiome research has expanded rapidly over the past 15 years; however, the primary focus has been on the gut microbiome. Although understudied, the vaginal microbiome holds significant potential to improve women's health. In this paper, we describe the current clinical diagnostic techniques utilised in women's health and examine their drawbacks and limitations. We also discuss emerging diagnostic technologies based on microbiome analysis that could enable greater precision in diagnosis and personalised treatment. We additionally emphasise the need for standardisation in microbiome analysis and strengthening the knowledge base to enable advancements in accurate diagnosis, ultimately improving patient outcomes. This article aims to highlight opportunities in the field that can transform women's health outcomes and outline the necessary actions to realise these opportunities, thereby enhancing women's lives.

Indexed as

MicrobiotaVaginaWomen's HealthFemaleHumansdiagnosticspersonalised treatmentstandardisationvaginal microbiomewomen’s health

Identifiers

PMID40851803
PMCPMC12367778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.